News by subject: HEALTH

Irwin Naturals Inc.  (FRA: 97X) ("Irwin" or the "Company") entered into a binding agreement on October 30, 2022, to acquire the assets of Clare Clinic, Inc., d/b/a Florida Mind Health Center, which operates three healthcare clinics in Florida. The...

Kane Biotech Inc. (the "Company" or "Kane Biotech") announces that it has recently submitted a 510(k) premarket notification, which has been received by The Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration...

Helius Medical Technologies will showcase its innovative new Portable Neuromodulation Stimulator (PoNS®) at the 99th annual American Congress of Rehabilitation Medicine (ACRM) Conference, held November 8-11 in Chicago. Visitors to booth 512 will see...

Earlier this year the Medical Innovation Xchange (MIX) announced an innovative partnership with the Ontario Ministry of Labour, Immigration, Training and Skills Development called the MIX Knowledge Xchange (MIX-KX). The goal of the MIX-KX is to...

PharmAla Biotech is pleased to announce that it has submitted its pre-IND data meeting package to the US Food and Drug Administration (USFDA) in advance of its pre-IND meeting scheduled for later this month. PharmAla will be requesting FDA feedback...

HBsAg and HBV DNA remain at low levels with no evidence of clinical relapse up to 44 weeks after discontinuing AB-729 and NA therapy Preclinical data suggest that AB-101, an oral PD-L1 inhibitor, in combination with an RNAi, may provide enhanced HBV...

Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced it will report its third quarter 2022 financial and operating results after the close of U.S. financial markets on Tuesday, November 8, 2022. Conference...

Arthritis Society Canada is investing in entrepreneurs to help them change the lives of people living with arthritis. For the second year in a row, Canada's leading arthritis charity is challenging entrepreneurs to invent and tailor practical...

Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that the Company will be presenting three...

Global leaders in the plant-based food and ingredient sector are gathering at The Westin Harbour Castle in Toronto, Ontario for Plant Forward, on November 1 & 2 to shape the future of plant-based food. The event, designed to highlight Canada's...

Rakovina Therapeutics Inc. ("the Company"), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response (DDR) technologies, is pleased to announce the presentation of new data during the 34th...

CloudMD Software & Services Inc. (the "Company" or "CloudMD"), a healthcare technology and innovative health services company transforming the delivery of care, is pleased to announce that it has entered into a definitive agreement (the "Agreement")...

Biotech innovator, Conagen announced the development of its fermentation-derived vitamin K2 - a high-purity all-trans menaquinone-7 (MK-7).  This is the first molecule from a proprietary platform for producing novel, pure, long-chain menaquinone...

RTOERO volunteers and staff met with Ontario MPPs and government officials during the sixth annual Vibrant Voices Advocacy event on Oct. 24 and 25. During virtual meetings on Oct. 24 and an in-person breakfast on Oct. 25, RTOERO Board of Directors,...

For Canadians diagnosed with brain cancer, where they live determines how much access they have to treatment, according to new research by the charity Brain Cancer Canada. A survey by the national organization shows that access to chemotherapy for...

Canadian MedTech company, PKA SoftTouch's patented Micro-Needle has concluded its veterinary clinical trials at the University of Guelph, ON. The results show the device significantly out-performs the traditional syringe injection through enhanced...

Eat & Beyond Global Holdings Inc. ("Eat & Beyond" or the "Company"), an investment issuer focused on food technology and the global plant-based and alternative protein sector, is announcing that its portfolio company Beyond Moo Foods ("Beyond...

Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that it has scheduled its third quarter 2022...

InMed Pharmaceuticals Inc. ("InMed" or the "Company") , a leader in the research, development and manufacturing of rare cannabinoids, announces it is supporting initiatives to raise awareness of epidermolysis bullosa, a group of rare genetic...

Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused on the development and commercialization of innovative therapies...

XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce receipt of a further no objection letter (NOL)...

Final safety and efficacy results from the Phase 3 EVOLVE-MS-1 trial demonstrate decreases in disease activity and favorable tolerability for VUMERITY® (diroximel fumarate) consistent with previous assessmentsPatient-reported outcomes favored...

Casey House ? a hospital unlike any other providing care to those living with and at risk of HIV ? is utilizing cinematic horror to bring attention to HIV stigma. Others ? directed by renowned filmmaker and screenwriter Paul Shkordoff - sets out...

Holy Cow Foods Inc. (NEO: HOLY; OTC: HCWFF; Frankfurt: Z34) ("Holy Cow" or the "Company") is pleased to announce an initiative to develop facilities incorporating automated robotic machinery powered by green hydrogen. The initiative was designed to...

Covis Pharma Group ("Covis"), a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses, today announced positive topline results from the AVANT phase 3 clinical...

Researchers at the UCSF QBI Coronavirus Research Group (QCRG) have uncovered how the SARS-CoV-2 variants of concern (VOC) differ in their ability to manipulate human cells on a molecular level during infection. They have discovered variant specific...

Canadian expertise in obesity prevention and treatment has made the leap across the Atlantic, as Ireland unveils new Adult Clinical Practice Guidelines (CPGs) for obesity treatment rooted in CPGs published by Obesity Canada and the Canadian...

October 25, 2022 Philips showcases innovations in its end-to-end stroke care pathway solutions aimed at improving treatment and quality of life for stroke patients Symposium hosted by Philips features leading clinical experts discussing early...

Across Ontario, the hospital crisis continues to burn through the resilience of the province's truly heroic health care staff. As the burden of infectious disease has increased, with the removal of virtually all public health measures to mitigate the...

New report addresses a fundamental gap in men's mental health research and identifies workplace factors that contribute to poor mental health for men.Nearly half of respondents were above the threshold for probable major depression, pointing to a...

Taconic Biosciences, a global leader in providing drug discovery animal model solutions, has launched the FcResolvtm NOG portfolio, the first and only super immunodeficient mouse models lacking residual murine Fc gamma receptors (Fc?Rs) known to...

An international collaboration between Bruce Power, Isogen (a Kinectrics and Framatome company) and ITM Isotope Technologies Munich SE (ITM), announced today the commencement of commercial production of lutetium-177.    The announcement was...

October 24, 2022 Highlights Group sales amounted to EUR 4.3 billion, with a 5% comparable sales decline, in line with the update provided on October 12, 2022Comparable order intake decreased 6% on the back of 47% growth in Q3 2021Income...

Royal Inland Hospital Foundation and Teck Resources Limited ("Teck") are joining today to celebrate the beginning of construction of the new Teck Emergency Department at Royal Inland Hospital (RIH). Teck contributed $2.5 million towards the...

Novan, Inc. ("the Company" or "Novan") , EPI Health, a Novan Company, and MC2 Therapeutics today announced positive data demonstrating the impact of PAD Technologytm in WYNZORA® Cream in three posters featured at the 42nd Annual Fall Clinical...

Canadian healthcare professionals who support patients living with obesity now have up-to-date information on the latest evidence for two important obesity treatment paradigms: medical nutrition therapy (MNT) and pharmacotherapy. Obesity Canada and...

According to The Ontario Health Coalition, the Ford government has ceased regular reporting on the spread of COVID-19. Public Health no longer publishes daily and weekly epidemiologic reports and it has become steadily more difficult to get accurate...

October 20, 2022 FDA 510(k) clearance for AI-enabled Philips MR for Calculating Attenuation (MRCAT) Head and Neck radiotherapy application expands range of MR-only workflows MacroMedics' positioning mask system [1] now compatible with Philips MR...

IntelGenx Corp.  (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 11,471,406 to IntelGenx, with claims for modulating drug absorption...

Avicanna Inc. ("Avicanna" or the "Company") , a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, is pleased to announce that it has formalized its provisional...

Providence Therapeutics Holdings Inc. ("Providence") today announced positive top-line data from the PRO-CL-002 Phase 2 study evaluating the safety, tolerability and immunogenicity of its mRNA COVID-19 vaccine candidate,...

Canadian Nurses Foundation, a national charity that invests in nursing education and research through bursaries, scholarships and grants, is set to host The Night Shift: Lighting Up the Night for Nurses on November 17, 2022 at the National Arts...

Bright Peak Therapeutics, a privately held biotechnology company leveraging a revolutionary chemical protein engineering platform to develop next-generation multifunctional cytokine-based immunotherapies, today announced the formation of a Scientific...

Aptose Biosciences Inc. , a clinical- stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, will report financial results for the quarter ended September 30, 2022, on Tuesday,...

Robotic and endoscopic spine surgeon Dr. Michael Gallizzi joined The Steadman Clinic surgical team in March and has quickly made his presence known on the Clinic's elite team of surgeons. In April, Dr. Gallizzi joined a short list of spinal...

IntelGenx Corp.  (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that it has responded to the Complete Response Letter ("CRL") for its 505(b)(2) New Drug Application (NDA) for RIZAPORT® VersaFilm® received from the...

Avicanna Inc. ("Avicanna" or the "Company") , a...

From the makers of INSTI®, bioLytical launches a new platform, iStatis, created to ensure every person in the world has access to reliable testingbioLytical receives eligibility for its self-test, the iStatis COVID-19 Antigen Home Test, for...

Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to announce that it is receiving advisory...

Assure Holdings Corp. (the "Company" or "Assure") , a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, is pleased to announce that it has performed its first neuromonitoring case in the state of New Jersey. Assure...